Recent Posts

• Ballot initiative takes shape to give California stem cell agency a second life
• ISCT Statement of Concern Regarding Speculative Commercial Cell Banking Services
• Dynamic Star Appoints Meridian Capital Group to Obtain Equity and Debt for $3.5 Billion Historic Development Along Harlem River in the Bronx, NY
• Commentary: Why California’s landmark stem cell agency deserves more funding
• Bernard “Burn” Loeffke & Dr. Randy Miller address the World Stem Cell Summit-CHINA “Bridges of Medical Friendship”
• Gene editing tool gets sharpened by WFIRM team
• World Stem Cell Summit-CHINA and Phacilitate Leaders Asia taking place, October 15-16, at the Kerry Hotel Pudong Shanghai
• Join Us: Sept 19 Congressional Lunch Briefing on Regenerative Cell Therapies
• Study shows Mesenchymal Stromal Cells importance of tissue origin in predicting function
• Bernie Siegel: Observations on my 70th birthday
• At last! Google policy bars ads for unproven stem cell and gene therapies – acknowledges “good actors”
• Study shows stem cells may be better choice than tissue transplantation for treating LSCD
• FDA sends warning to company for selling unapproved umbilical cord blood and umbilical cord products that may put patients at risk; continues to warn patients of the risk of unapproved stem cell therapy
• Woman is first to receive cornea made from ‘reprogrammed’ stem cells
• The ‘unwarranted hype’ of stem cell therapies